A Study to Compare the Relative Bioavailability of Two 200 Mg Tramadol Hydrochloride Tablet Products Under Fasting Conditions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2012-04-30
- Lead Sponsor
- Labopharm Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT00834366
Study of Two Tramadol Contramid® OAD 300 mg Controlled-Release Tablets From Two Different Manufacturing Sites Following a 300 mg Dose in Healthy Subjects Under Fasting and Fed Conditions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2012-04-30
- Lead Sponsor
- Labopharm Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT00834912
A Dose Linearity Study of the Labopharm Formulation of Tramadol HCl/Contramid®, 100 mg, 200 mg and 300 mg After A Single Oral Administration In Fasting Condition, In Healthy Human Volunteers
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2012-04-27
- Lead Sponsor
- Labopharm Inc.
- Target Recruit Count
- 27
- Registration Number
- NCT00834808
A Study to Compare the Bioavailability of Two Tramadol Hydrochloride Tablet Products (50 mg and 200 mg, Respectively) at Steady-state Under Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy SubjectsPharmacokineticsBioavailability
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2012-04-27
- Lead Sponsor
- Labopharm Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT00834288
A Two-Arm Study Comparing the Analgesic Efficacy and Safety of Tramadol HCl Once-a-Day Versus Placebo for the Treatment of Pain Due to Osteoarthritis
- First Posted Date
- 2009-02-02
- Last Posted Date
- 2012-04-30
- Lead Sponsor
- Labopharm Inc.
- Target Recruit Count
- 1028
- Registration Number
- NCT00833794
An Open-Label Long-term Safety Study of Tramadol HCl OAD (Once A Day) 300 mg in the Treatment of Pain Due to Osteoarthritis of the Knee
- First Posted Date
- 2009-02-02
- Last Posted Date
- 2012-04-30
- Lead Sponsor
- Labopharm Inc.
- Target Recruit Count
- 392
- Registration Number
- NCT00833911
A Four-Arm Study Comparing the Analgesic Efficacy and Safety of Tramadol Once a Day 100, 200 and 300 mg Versus Placebo for the Treatment of Pain Due to Osteoarthritis of the Knee
Phase 3
Completed
- Conditions
- PainOsteoarthritis, Knee
- Interventions
- Drug: Placebo
- First Posted Date
- 2009-01-30
- Last Posted Date
- 2012-04-30
- Lead Sponsor
- Labopharm Inc.
- Target Recruit Count
- 565
- Registration Number
- NCT00832416
A Randomized, Double-blind, Two-arm Study Comparing the Efficacy and Safety of Trazodone Contramid® OAD and Placebo in the Treatment of Unipolar Major Depressive Disorder.
Phase 3
Completed
- Conditions
- Major Depressive Disorder
- Interventions
- First Posted Date
- 2008-10-20
- Last Posted Date
- 2012-04-27
- Lead Sponsor
- Labopharm Inc.
- Target Recruit Count
- 412
- Registration Number
- NCT00775203
A Two-Arm Study Comparing the Analgesic Efficacy and Safety of Acetaminophen and Tramadol Combination BID Versus Placebo for the Treatment of Acute Low Back Pain
Phase 3
Completed
- Conditions
- Acute Low Back Pain
- Interventions
- Drug: Combination drug (Acetaminophen + Tramadol)Drug: Placebo
- First Posted Date
- 2008-03-26
- Last Posted Date
- 2012-05-01
- Lead Sponsor
- Labopharm Inc.
- Target Recruit Count
- 277
- Registration Number
- NCT00643383
© Copyright 2025. All Rights Reserved by MedPath